Deferred initiation of ART may increase risk for AIDS-defining cancer among patients living with HIV

Deferred antiretroviral therapy (ART) initiation in ART-naive, HIV-positive persons is associated with a small increase in risk for AIDS-defining cancer. These findings add to the evidence that early ART may reduce risk for non-AIDS-defining cancer. A multinational prospective cohort study is published in Annals of Internal Medicine.